Cannabis
Cannabis Growth Opportunity Corporation Announces NAV of $2.51
Cannabis Growth Opportunity Corporation (“CGOC“, or the “Company“) (CSE: CGOC), a cannabis-focused investment corporation with both public and private cannabis holdings, announces the company’s updated net asset value per common share (“NAV“) of $2.51 at the close of business on November 15, 2019. This represents growth of 8% since the Initial Public Offering (“IPO“), on January 26, 2018, and a decrease of 9% year to date.
CGOC is invested in companies operating in Canada, the U.S., Europe, Latin America, Jamaica and Israel, with an investment split across the private and public portfolios of approximately 40% and 60% respectively. CGOC’s top ten public investments as of November 15, 2019 (in alphabetical order) are: Bhang Inc (CSE: BHNG), C21 Investments (CSE: CXXI); Grassroots Cannabis, (not yet listed), Heritage Cannabis (CSE: CANN), Jushi Holdings Inc. (NEO: JUSH.B), LPF Investment Corp. (“Loudpack”, not yet listed) Next Green Wave (CSE: NGW), Planet 13 Holdings Inc. (CSE: PLTH), TerrAscend Corp. (CSE: TER), and VIVO Cannabis Inc. (TSX-V: VIVO).
Sean Conacher, Chief Executive Officer of CGOC commented, “CGOC realized a loss of 3% over last month compared to the North American Marijuana Index, which realized a 17% loss. Since CGOC’s IPO, our NAV has grown by 8% compared to the NAMMAR, as well as a number of other market indices which declined by an average of 66% in the same time period.
“The private portfolio continued to contribute positively to the overall portfolio performance, especially those outside of Canada. Our strategy of seeking out experienced and globally well positioned companies has allowed us to gain global exposure and invest relatively early on as illustrated by our investment in I.M.C Holdings Ltd. (now IM Cannabis Corp, CSE: IMCC) which listed on the Canadian Securities Exchange on November 5, 2019, to become the first Israeli medical cannabis operator to list its shares in Canada.”
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis3 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care